About the Foundation for Mitochondrial Medicine
The Foundation for Mitochondrial Medicine (FMM) supports the development of the most promising mitochondrial disease research and treatments of the many forms of mitochondrial disease. Formed in 2005 and renamed in 2010, our Atlanta-based non-profit organization financially supports treatment basedresearch. From functional brain MRI studies on cognitive fatigue to testing of new drug compounds, including the first FDA-approved drug treatments that began in early 2010, FMM focuses on supporting Institutional Review Board (IRB) or FDA approved studies. Support is provided for personnel costs, supplies (i.e., consumables, chemicals, animals), small non-durable equipment up to $2,500. Support is not provided for indirect costs/overhead, capital equipment, equipment service contracts, publication costs, or travel.
The foundation’s stewards and founders are parents of patients and medical experts. We were created to accelerate the development of the most viable mitochondrial disease treatments and therapies.
Our Mission and Priorities
Simply put, our purpose is to support the development of the most promising mitochondrial disease research and treatments. We’re funding a path to the cure, making connections to other related diseases and leading our stakeholders to the right information and the best answers.
As the Foundation for Mitochondrial Medicine looked to define its voice and purpose, we recognized that we wanted be an organization strategically connected to “hope and positivity.” In seeking an image for our logo, we needed to literally look no further than our own backyard-the firefly, long the symbol of guidance and illumination sparks our energies, both metaphorically and scientifically.
The enchanting firefly may hold an important key to understanding mitochondrial disease and studying the way cells use energy. In mitochondrial diseases, the body cannot make enough energy, or ATP.
To measure ATP in each cell, scientists are currently using the material found in a firefly’s tail light – luciferase – mixed with a recombinant DNA to study cell energy production. Information gathered from luciferase research has the potential for use in a broad array of applications, including drug discovery, patient diagnoses, patient treatment and disease monitoring. And, this firefly links to treatment and hope, becoming a natural embodiment of inspiration for our story.